| | |
PER SHARE
|
| |
PER
PRE-FUNDED WARRANT |
| |
TOTAL
|
| ||||||
Public Offering Price
|
| | | $ | | | | | | | | $ | | | ||
Underwriting Discounts and Commissions(1)
|
| | | $ | | | | | | | | | $ | | | |
Proceeds to Abeona Therapeutics Inc., before expenses
|
| | | $ | | | | | | | | | $ | | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-2 | | | |
Summary | | | | | S-4 | | |
| | | | S-5 | | | |
| | | | S-7 | | | |
| | | | S-9 | | | |
Dilution | | | | | S-10 | | |
| | | | S-11 | | | |
Underwriting | | | | | S-13 | | |
| | | | S-19 | | | |
Experts | | | | | S-20 | | |
| | | | S-20 | | | |
Prospectus
|
| | |||||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 6 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 30 | | | |
| | | | 33 | | | |
| | | | 34 | | | |
| | | | 36 | | | |
| | | | 37 | | | |
| | | | 38 | | | |
| | | | 43 | | | |
| | | | 44 | | | |
| | | | 44 | | |
|
Public offering price per share
|
| | | | | | | | | $ | | | |
|
Net tangible book value per share as of September 30, 2019
|
| | | $ | 0.51 | | | | | | | | |
|
Increase per share attributable to new investors
|
| | | $ | | | | | | | | | |
|
As adjusted net tangible book value per share as of September 30, 2019, after giving effect to this offering
|
| | | | | | | | | $ | | | |
|
Dilution per share to new investors purchasing shares in this offering
|
| | | | | | | | | $ | | | |
|
| | |
Per Share
|
| |
Total
|
| ||||||||||||||||||
| | |
Without
Option to Purchase Additional Shares |
| |
With Option
to Purchase Additional Shares |
| |
Without
Option to Purchase Additional Shares |
| |
With Option
to Purchase Additional Shares |
| ||||||||||||
Public offering price per share of common stock
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Public offering price per pre-funded warrant
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Underwriting discounts and commissions paid by us
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Proceeds to us, before expenses
|
| | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 6 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 30 | | | |
| | | | 33 | | | |
| | | | 34 | | | |
| | | | 36 | | | |
| | | | 37 | | | |
| | | | 38 | | | |
| | | | 43 | | | |
| | | | 44 | | | |
| | | | 44 | | |